Dilantin (phenytoin) is a small molecule pharmaceutical. Phenytoin was first approved as Dilantin on 1982-01-01. It is used to treat epilepsy, status epilepticus, temporal lobe epilepsy, and tonic-clonic epilepsy in the USA. The pharmaceutical is active against sodium channel protein type 2 subunit alpha.
|Indication||epilepsy, status epilepticus, temporal lobe epilepsy, tonic-clonic epilepsy|
|Drug Class||Antiepileptics (hydantoin derivatives)|